What is the Impact Factor of Current Opinion in Drug Discovery & Development?

The journal Current Opinion in Drug Discovery & Development is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Current Opinion in Drug Discovery & Development indexed in Web of Science or Scopus?

Yes, Current Opinion in Drug Discovery & Development is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of N/A (Q1) and an H-index of N/A.

Who publishes Current Opinion in Drug Discovery & Development and what is the Article Processing Charge (APC)?

Current Opinion in Drug Discovery & Development is published by International Academic Publisher. For exact article processing charges and subscription guidelines, consult the official editorial guidelines.

What is the ISO-4 abbreviation and acronym of Current Opinion in Drug Discovery & Development?

The official ISO-4 abbreviation of Current Opinion in Drug Discovery & Development is "Curr. Opin. Drug Discovery Dev". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Subscription

Current Opinion in Drug Discovery & Development

Abbreviation (ISO):Curr. Opin. Drug Discovery Dev

•

Identifier (ISSN):1367-6733(Print)

Clarivate JCR Index Advisory: Not Indexed in Latest JCR

Official Website Submission Portal Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend (2018–2023)

Clarivate IF trend for Current Opinion in Drug Discovery & Development

WoS Q1

Annual Impact Factor Metric

Current (2023):0

Scopus SJR & Rank

N/A

SCImago Journal Rank citation prestige weighting

Scopus / Elsevier Data

H-Index (Hirsch Index)

N/A

papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessSubscription

0articles/year

0% Gold OA•0% Original Research

Aims & Scope

Current Opinion in Drug Discovery & Development (abbr: Curr. Opin. Drug Discovery Dev, ISSN: 1367-6733) is a peer-reviewed international scholarly journal in the field of Medicine, in England since 1998. The periodical holds tracked under Web of Science (SCIE) in quartile Q1.

Topics Covered (Recognized by AI)

Biology93.8%Chemistry89.5%Biochemistry81.8%Medicine68.2%Genetics64.7%Bioinformatics48.1%Computer science47.9%Internal medicine44.8%Computational biology44.7%Physics40.3%Pharmacology38.8%Organic chemistry36.8%Psychology34.3%Drug discovery33.6%Gene30.3%Engineering28.5%Psychiatry28%Drug24%Nuclear magnetic resonance21.8%Materials science20.8%

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

11 year

2023Latest

IF0

Articles / Year—

Total Citations—

2019

IF0

Articles / Year—

Total Citations—

2018

IF0

Articles / Year—

Total Citations—

2014

IF—

Articles / Year1

Total Citations0

2013

IF—

Articles / Year1

Total Citations0

Year	Impact Factor	Articles / Year	Total Citations
2023	0	—	—
2019	0	—	—
2018	0	—	—
2014	—	1	0
2013	—	1	0
2010	—	1	0
2003	—	2	11
1998	—	1	0
1995	—	1	13
1991	—	1	0
1966	—	1	0

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

Updating

Minor Category (Specific Field):

Updating

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 0 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with APC fees are not specified. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.